Proposed Data Collection Submitted for Public Comment and Recommendations, 3711-3712 [2018-01381]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 18 / Friday, January 26, 2018 / Notices
of Labor v. Mach Mining, LLC, Docket
Nos. LAKE 2014–77, et al. (Issues
include whether the Judge erred by
ruling that the operator did not violate
a standard requiring that electrical
protection devices on high voltage
longwall equipment be properly
maintained.)
Any person attending this meeting
who requires special accessibility
features and/or auxiliary aids, such as
sign language interpreters, must inform
the Commission in advance of those
needs. Subject to 29 CFR 2706.150(a)(3)
and § 2706.160(d).
CONTACT PERSON FOR MORE INFO:
Emogene Johnson (202) 434–9935/(202)
708–9300 for TDD Relay/1–800–877–
8339 for toll free.
PHONE NUMBER FOR LISTENING TO
MEETING: 1–(866) 867–4769, Passcode:
678–100.
[FR Doc. 2018–01529 Filed 1–24–18; 11:15 am]
BILLING CODE 6735–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–18–1046; Docket No. CDC–2018–
0008]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled National Breast and Cervical
Cancer Early Detection Program
(NBCCEDP) Monitoring Activities. CDC
is requesting a revision to this
information collection project to include
a redesigned survey and a new cliniclevel data collection.
DATES: CDC must receive written
comments on or before March 27, 2018.
daltland on DSKBBV9HB2PROD with NOTICES
VerDate Sep<11>2014
20:14 Jan 25, 2018
Jkt 244001
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT:
Sarah L. Stewart,
Deputy General Counsel.
SUMMARY:
You may submit comments,
identified by Docket No. CDC–2018–
0008 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
ADDRESSES:
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
3711
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
National Breast and Cervical Cancer
Early Detection Program (NBCCEDP)
Monitoring Activities—(OMB No. 0920–
1046, exp. 01/31/2018)—Reinstatement
with Change—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC is requesting a revision of the
information collection with the OMB
Control Number 0920–1046, formerly
entitled ‘‘Annual Survey of the National
Breast and Cervical Cancer Early
Detection Program Grantees’ Program
Implementation’’. We are proposing a
new title, ‘‘National Breast and Cervical
Cancer Early Detection Program
(NBCCEDP) Monitoring Activities.’’ In
the previous OMB approval period,
information collection consisted of an
annual grantee survey. In the next OMB
approval period, information collection
will consist of a redesigned survey and
a new clinic-level data collection. The
number of respondents will increase
from 67 to 70, and the total estimated
annualized burden will increase from 45
to 683.
Breast and cervical cancers are
prevalent among women in the United
States. In 2014, more than 236,000
women were diagnosed with breast
cancer, and more than 12,000 women
were diagnosed with cervical cancer.
Evidence shows that deaths from both
breast and cervical cancers can be
avoided by increasing screening services
among women. However, screening is
typically underutilized among women
who are under- or uninsured, have no
regular source of healthcare, or who
recently immigrated to the U.S. As a
longstanding priority within chronic
disease prevention, CDC focuses on
increasing access to these cancer
screenings, particularly among women
who may be at increased risk.
To improve access to cancer
screening, Congress passed the Breast
and Cervical Cancer Mortality
Prevention Act of 1990 (Pub. L. 101–
354), which directed CDC to create the
National Breast and Cervical Cancer
Early Detection Program (NBCCEDP).
The NBCCEDP currently provides
E:\FR\FM\26JAN1.SGM
26JAN1
3712
Federal Register / Vol. 83, No. 18 / Friday, January 26, 2018 / Notices
funding to 70 grantees under ‘‘Cancer
Prevention and Control Programs for
State, Territorial, and Tribal
Organizations (DP17–1701).’’ NBCCEDP
grantees include states or their bona fide
agents; U.S. territories; and tribes or
tribal organizations. The purpose of
NBCCEDP is to increase breast and
cervical cancer screening rates among
women residing within defined
geographical locations (as determined
by the funded program) who are at or
below 250% of the federal poverty level;
aged 40–64 years for breast cancer
services, and aged 21–64 years for
cervical cancer services; and under- or
uninsured.
The NBCCEDP was significantly
redesigned in 2017 to expand its focus
on direct service provision to include
implementation of evidence-based
and annual clinic-level data for all
partnering health system clinic sites—
an estimated 6 clinics per grantee for
breast cancer data and 6 clinics per
grantee for cervical cancer data. All
information will be reported to CDC
electronically.
The proposed information collections
will allow CDC to gauge progress in
meeting NBCCEDP program goals and
monitor implementation activities,
evaluate outcomes, and identify grantee
technical assistance needs. In addition,
findings will inform program
improvement and help identify
successful activities that need to be
maintained, replicated, or expanded.
CDC seeks a three-year OMB
approval. Participation is required for
NBCCEDP grantees. There are no costs
to respondents other than their time.
interventions (EBIs) intended to
increase breast and cervical cancer
screening at the population level. Based
on the redesigned NBCCEDP, the
information collection plan has also
been redesigned. CDC is required to
monitor and evaluate processes and
outcomes related to the NBCCEDP.
CDC proposes two forms of
information collection. First, the
NBCCEDP Grantee Survey was
reconstructed to reflect the focus of the
redesigned program under DP17–1701.
The grantee survey will be submitted to
CDC annually. Second, CDC proposes to
collect clinic-level data to assess EBI
implementation and the NBCCEDP’s
primary outcome of interest—breast and
cervical screening rates within partner
health system clinics. NBCCEDP
grantees will collect and report baseline
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
NBCCEDP Grantees .........................
NBCCEDP Grantees .........................
NBCCEDP Grantee Survey .............
NBCCEDP Clinic-level Information
Collection Instrument—Breast.
NBCCEDP Clinic-level Information
Collection Instrument—Cervical.
NBCCEDP Grantees .........................
Total ...........................................
...........................................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2018–01381 Filed 1–25–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
daltland on DSKBBV9HB2PROD with NOTICES
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting for the Subcommittee
on Dose Reconstruction Review (SDRR)
SUMMARY:
VerDate Sep<11>2014
20:14 Jan 25, 2018
Jkt 244001
45/60
45/60
53
315
70
6
45/60
315
........................
........................
........................
683
The meeting will be held on
March 13, 2018, 10:30 a.m. to 4:30 p.m.
EDT.
Audio Conference Call via
FTS Conferencing. The USA toll-free
dial-in number is 1–866–659–0537; the
pass code is 9933701.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Theodore Katz, MPA, Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road, Mailstop E–20, Atlanta,
Georgia 30333, Telephone (513) 533–
6800, Toll Free 1 (800) CDC–INFO,
Email ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Fmt 4703
Total burden
(in hours)
1
6
DATES:
Frm 00040
Average
burden per
response
(in hours)
70
70
of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, but without a
public comment period. The public is
welcome to submit written comments in
advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
teleconference at the USA toll-free, dialin number at 1–866–659–0537; the pass
code is 9933701. The conference line
has 150 ports for callers.
PO 00000
Number of
responses
per
respondent
Sfmt 4703
Background: The Advisory Board as
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
rechartered on March 22, 2016,
E:\FR\FM\26JAN1.SGM
26JAN1
]]>Agencies
[Federal Register Volume 83, Number 18 (Friday, January 26, 2018)]
[Notices]
[Pages 3711-3712]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-01381]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-18-1046; Docket No. CDC-2018-0008]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled National Breast and Cervical
Cancer Early Detection Program (NBCCEDP) Monitoring Activities. CDC is
requesting a revision to this information collection project to include
a redesigned survey and a new clinic-level data collection.
DATES: CDC must receive written comments on or before March 27, 2018.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0008 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal
eRulemaking portal (regulations.gov) or by U.S. mail to the address
listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Leroy A. Richardson, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
National Breast and Cervical Cancer Early Detection Program
(NBCCEDP) Monitoring Activities--(OMB No. 0920-1046, exp. 01/31/2018)--
Reinstatement with Change--National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CDC is requesting a revision of the information collection with the
OMB Control Number 0920-1046, formerly entitled ``Annual Survey of the
National Breast and Cervical Cancer Early Detection Program Grantees'
Program Implementation''. We are proposing a new title, ``National
Breast and Cervical Cancer Early Detection Program (NBCCEDP) Monitoring
Activities.'' In the previous OMB approval period, information
collection consisted of an annual grantee survey. In the next OMB
approval period, information collection will consist of a redesigned
survey and a new clinic-level data collection. The number of
respondents will increase from 67 to 70, and the total estimated
annualized burden will increase from 45 to 683.
Breast and cervical cancers are prevalent among women in the United
States. In 2014, more than 236,000 women were diagnosed with breast
cancer, and more than 12,000 women were diagnosed with cervical cancer.
Evidence shows that deaths from both breast and cervical cancers can be
avoided by increasing screening services among women. However,
screening is typically underutilized among women who are under- or
uninsured, have no regular source of healthcare, or who recently
immigrated to the U.S. As a longstanding priority within chronic
disease prevention, CDC focuses on increasing access to these cancer
screenings, particularly among women who may be at increased risk.
To improve access to cancer screening, Congress passed the Breast
and Cervical Cancer Mortality Prevention Act of 1990 (Pub. L. 101-354),
which directed CDC to create the National Breast and Cervical Cancer
Early Detection Program (NBCCEDP). The NBCCEDP currently provides
[[Page 3712]]
funding to 70 grantees under ``Cancer Prevention and Control Programs
for State, Territorial, and Tribal Organizations (DP17-1701).'' NBCCEDP
grantees include states or their bona fide agents; U.S. territories;
and tribes or tribal organizations. The purpose of NBCCEDP is to
increase breast and cervical cancer screening rates among women
residing within defined geographical locations (as determined by the
funded program) who are at or below 250% of the federal poverty level;
aged 40-64 years for breast cancer services, and aged 21-64 years for
cervical cancer services; and under- or uninsured.
The NBCCEDP was significantly redesigned in 2017 to expand its
focus on direct service provision to include implementation of
evidence-based interventions (EBIs) intended to increase breast and
cervical cancer screening at the population level. Based on the
redesigned NBCCEDP, the information collection plan has also been
redesigned. CDC is required to monitor and evaluate processes and
outcomes related to the NBCCEDP.
CDC proposes two forms of information collection. First, the
NBCCEDP Grantee Survey was reconstructed to reflect the focus of the
redesigned program under DP17-1701. The grantee survey will be
submitted to CDC annually. Second, CDC proposes to collect clinic-level
data to assess EBI implementation and the NBCCEDP's primary outcome of
interest--breast and cervical screening rates within partner health
system clinics. NBCCEDP grantees will collect and report baseline and
annual clinic-level data for all partnering health system clinic
sites--an estimated 6 clinics per grantee for breast cancer data and 6
clinics per grantee for cervical cancer data. All information will be
reported to CDC electronically.
The proposed information collections will allow CDC to gauge
progress in meeting NBCCEDP program goals and monitor implementation
activities, evaluate outcomes, and identify grantee technical
assistance needs. In addition, findings will inform program improvement
and help identify successful activities that need to be maintained,
replicated, or expanded.
CDC seeks a three-year OMB approval. Participation is required for
NBCCEDP grantees. There are no costs to respondents other than their
time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Grantees.............. NBCCEDP Grantee 70 1 45/60 53
Survey.
NBCCEDP Grantees.............. NBCCEDP Clinic- 70 6 45/60 315
level
Information
Collection
Instrument--Bre
ast.
NBCCEDP Grantees.............. NBCCEDP Clinic- 70 6 45/60 315
level
Information
Collection
Instrument--Cer
vical.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 683
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-01381 Filed 1-25-18; 8:45 am]
BILLING CODE 4163-18-P
